← Open Payments lookup

CAROL VORENKAMP-COOPER: Open Payments

NPI 1669461992 · OWOSSO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$266 in 13 payments from 8 companies in 2025. Trend: 2023 $180 · 2024 $339 · 2025 $266

Food & beverage: $266
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$96
Amgen Inc.3$58
ARS Pharmaceuticals Operations, Inc.1$22
Novo Nordisk Inc1$20
Axsome Therapeutics, Inc.1$19
E.R. Squibb & Sons, L.L.C.1$18
Xeris Pharmaceuticals, Inc.1$17
Janssen Pharmaceuticals, Inc1$16

Products named: CAPLYTA, OTEZLA, NEFFY, Ozempic, Auvelity, ELIQUIS, GVOKE HYPOPEN, SPRAVATO.

Industry payments across MI — which companies pay providers there.